Need for Effective Analytical Platforms in Research to Reduce Operational Costs, Adoption of Companion Diagnostics for Increasing & efficacy of therapies, and Advantages of multiplexing over traditional assays Will Boost the Growth of the Multiplex Assays Market.

The global multiplex assays market is projected to reach USD 3.76 Billion by 2021 from USD 2.66 Billion in 2016, at a CAGR of 7.2% from 2016 to 2021.

Know More:
https://www.marketsandmarkets.com/Market-Reports/multiplex-assays-market-61593314.html

The multiplex assays market is segmented on the basis of products & service, type, technology, applications, end user, and region. By products & services, the market is categorized into instruments, consumables, accessories, software, and services. The MRI market by type is divided into nucleic acid-based multiplex assays and protein-based multiplex assays. By technology, the market is divides into multiplex polymerase chain reaction, multiplex arrays, and other technologies.

On the basis of applications, the multiplex assays market is categorized into research & development, diseases & disorders, companion diagnostics, and other applications. The research & development segment is expected to account for the largest share of the multiplex assays market in 2016. Factors such as convenience in performing the assays and faster results offered are driving the growth of this segment.

The end user segment of the multiplex assays market is segmented into academic and research institutes, hospitals, clinical laboratories, pharmaceutical and biotechnology companies, and other end users. The pharmaceutical and biotechnology companies segment is estimated to account for the largest share in 2016.

North America is expected to account for the largest share of the multiplex assays market in 2016. This region is estimated to account for 44.7% of the total market. Europe is the second-largest source, this regional market is driven by the availability of government funds.

Download PDF Brochure:
https://www.marketsandmarkets.com/pdfdownload.asp?id=61593314

Major players in the multiplex assays market include Luminex Corporation (U.S.), Thermo Fisher Scientific, Inc. (U.S.), Illumina, Inc. (U.S.), Bio-Rad Laboratories, Inc. (U.S.), and QIAGEN N.V. (Netherlands).